BEGIN:VCALENDAR
VERSION:2.0
PRODID:Linklings LLC
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260924T172350Z
LOCATION:B311
DTSTART;TZID=America/New_York:20241118T140000
DTEND;TZID=America/New_York:20241118T173000
UID:submissions.supercomputing.org_SC24_sess818@linklings.com
SUMMARY:Tenth Computational Approaches for Cancer Workshop
DESCRIPTION:Welcome\n\nEric Stahlberg (Frederick National Laboratory for C
 ancer Research)\n---------------------\nPanel: What is Healthy AI?\n\nAs a
  unifying theme in 2024, the special topic “What is Healthy AI?” will focu
 s on the intersection of technology and innovation with cancer biology. “W
 hat is Healthy AI” embarks on the journey to craft the correct components 
 for data and algorithms to seamlessly coexist with...\n\n\nEric Stahlberg 
 (Frederick National Laboratory for Cancer Research), Kristin Higgins (City
  of Hope), Kaylin Carey (Morehouse School of Medicine), Rishi Kamaleswaran
  (Duke University School of Medicine), and Walkitria Smith (Morehouse Scho
 ol of Medicine)\n---------------------\nLightning Round Virtual Poster Ses
 sion and Break\n\nLauren Lewis (Frederick National Laboratory for Cancer R
 esearch)\n---------------------\nWide-field Phase-Contrast Micro-CT and Co
 mputational Topology for the 3D Exploration of Prostate Cancer and other S
 oft Tissue Tumors\n\nThe diagnosis and grading of cancer rely on the exami
 nation of abnormal tissue and the morphology of the cells within. For exam
 ple, the clinical evaluation of prostate cancer requires the assessment of
  glandular and cellular morphology from histopathology images. However, pr
 ostate cancer patients su...\n\n\nAndrew Sugarman, Daniel Vanselow, and Jo
 shua Warrick (Pennsylvania State University); Dilworth Parkinson (Lawrence
  Berkeley National Laboratory (LBNL)); Patrick La Riviere (University of C
 hicago); and Justin Silverman and Keith Cheng (Pennsylvania State Universi
 ty)\n---------------------\nAnti-Cancer Drug Response Prediction on Patien
 t-Derived Xenografts: Learning from Extremely Limited Data\n\nCancer is a 
 family of complex genetic disorders characterized by the accumulation of g
 enetic and epigenetic alterations that drive uncontrolled cell growth and 
 metastasis. It is becoming a leading cause of death worldwide, accounting 
 for 10 million deaths in 2020. In 2024, NIH projects that roughly ...\n\n\
 nOleksandr Narykov, Yitan Zhu, and Thomas Brettin (Argonne National Labora
 tory (ANL)); Yvonne Evrard (Frederick National Laboratory for Cancer Resea
 rch); Priyanka Vasanthakumari, Alexander Partin, and Maulik Shukla (Argonn
 e National Laboratory (ANL)); James Doroshow (National Institutes of Healt
 h (NIH), National Cancer Institute (NCI)); and Rick Stevens (Argonne Natio
 nal Laboratory (ANL), University of Chicago)\n---------------------\nThe H
 allmarks of Predictive Oncology\n\nPredictive oncology can be defined as t
 he branch of precision medicine focused on improving cancer treatment outc
 omes by customizing therapeutic decisions for each patient based on all av
 ailable information – genetic, molecular, cellular, and clinical. The rapi
 d evolution of machine learning h...\n\n\nAkshat Singhal (University of Ca
 lifornia San Diego); Ryan Weil (Frederick National Laboratory for Cancer R
 esearch); Benjamin Haibe-Kains (University of Toronto, Canada); and Trey I
 deker (University of California San Diego)\n---------------------\nReprodu
 cible Radiology and Pathology Imaging Analysis using a Standard Model Infe
 rencing Architecture\n\nIt can be difficult for medical imaging researcher
 s to use machine learning (ML) models developed by others because usage co
 nventions vary greatly between developers. Additionally, many ML training 
 pipelines do not support the DICOM standard for medical imagery.   These f
 actors can make it difficult...\n\n\nCurtis Lisle (KnowledgeVis, LLC)\n---
 ------------------\nCross-HPO: Optimizing Neural Networks for Cancer Drug 
 Response Using Hyperparameter Tuning on Multiple Pharmacogenomic Datasets\
 n\nPredicting and comparing anti-cancer drug responses using deep learning
  models across datasets is a challenging modern problem. In this study, we
  optimized hyperparameters in several novel neural network-based models, i
 ncluding GraphDRP [1], IGTD [2], Paccmann [3], PathDSP [4], and HiDRA [5],
  and a ...\n\n\nRajeev Jain, Justin M. Wozniak, Alexander Partin, Andreas 
 Wilke, Yitan Zhu, Priyanka Vasanthakumari, Oleksandr Narykov, Jamie Overbe
 ek, and Rylie Weaver (Argonne National Laboratory (ANL)); Chen Wang and Yu
 anhang Liu (Mayo Clinic); Ryan Weil (National Institutes of Health (NIH));
  and Thomas Brettin and Rick Stevens (Argonne National Laboratory (ANL))\n
 ---------------------\nGeneralized Generative Molecular Design: An open so
 urce, Modular Tool for De Novo Drug Design\n\nThe chemical space of small 
 molecules is vast, making de novo drug design challenging. Traditional met
 hods are slow and costly. While AI advancements have improved this process
 , we still face limitations in exploring the larger chemical space. In onc
 ological drug discovery, various factors such as s...\n\n\nEli Brignac (Un
 iversity of Delaware) and Sean Black (Frederick National Laboratory for Ca
 ncer Research)\n---------------------\nPanel: Emerging Leaders\n\nThe disc
 ussion will focus on innovation, collaboration, and the critical role of f
 uture leaders in driving breakthroughs at the intersection of AI and healt
 hcare.\n\n\nKaylin Carey (Morehouse School of Medicine), Eli Brignac (Univ
 ersity of Delaware), Sean Black and Justin Overhulse (Frederick National L
 aboratory for Cancer Research), and Joel Duah (Bowie State University)\n--
 -------------------\nClosing Remarks\n\nEric Stahlberg (Frederick National
  Laboratory for Cancer Research)\n\nTag: Artificial Intelligence/Machine L
 earning, Biology, Broader Engagement, Education, Emerging Technologies, Me
 dicine, Modeling and Simulation\n\nRegistration Category: Workshop Reg Pas
 s\n\nSession Chairs: Lynn Borkon (UT MD Anderson, Institute for Data Scien
 ce in Oncology); Lauren Lewis (Frederick National Laboratory for Cancer Re
 search); and Eric Stahlberg (MD Anderson Cancer Center, University of Texa
 s)
END:VEVENT
END:VCALENDAR
